Cumberland Pharmaceuticals (CPIX) Intangibles (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Intangibles of $12.8 million for Q1 2026, down 8.8% sequentially from $14.0 million in Q4 2025, and down 24.69% YoY from $17.0 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Intangibles (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Intangibles for 17 years, with the latest figure at $12.8 million in Q1 2026.
- Quarterly Intangibles fell 24.69% year-over-year to $12.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.8 million (down 24.69% YoY) and the FY2025 annual result came in at $14.0 million, down 21.95% from the prior year.
- Intangibles declined to $12.8 million in Q1 2026 per CPIX's latest filing, from $14.0 million in the prior quarter.
- Over five years, Intangibles peaked at $34.5 million in Q1 2022 and troughed at $12.8 million in Q1 2026.
- A 5-year average of $22.9 million and a median of $21.5 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2024: Intangibles advanced 27.7% in 2022, then fell 28.41% in 2024.
- Over 5 years, Intangibles stood at $30.6 million in 2022, then fell by 26.1% to $22.6 million in 2023, then retreated by 20.5% to $18.0 million in 2024, then dropped by 21.95% to $14.0 million in 2025, then declined by 8.8% to $12.8 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $12.8 million, $14.0 million, and $15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 1.12 Bn |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - | 43,804.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43,804.00 |
| Mar 31, 2026 | 12.79 Mn |
| Dec 31, 2025 | 14.03 Mn |
| Sep 30, 2025 | 15.01 Mn |
| Jun 30, 2025 | 15.99 Mn |
| Mar 31, 2025 | 16.99 Mn |
| Dec 31, 2024 | 17.97 Mn |
| Sep 30, 2024 | 19.42 Mn |
| Jun 30, 2024 | 20.46 Mn |
| Mar 31, 2024 | 21.52 Mn |
| Dec 31, 2023 | 22.61 Mn |
| Sep 30, 2023 | 27.12 Mn |
| Jun 30, 2023 | 28.27 Mn |
| Mar 31, 2023 | 29.39 Mn |
| Dec 31, 2022 | 30.59 Mn |
| Sep 30, 2022 | 29.05 Mn |
| Jun 30, 2022 | 32.98 Mn |
| Mar 31, 2022 | 34.48 Mn |
| Dec 31, 2021 | 23.95 Mn |
| Sep 30, 2021 | 24.92 Mn |